Trelegy Ellipta vs Breztri Aerosphere
A side-by-side look at two respiratory medications advertised on TV. Informational only — not medical advice.
| US Trelegy Ellipta | US Breztri Aerosphere | |
|---|---|---|
| Generic name | fluticasone/umeclidinium/vilanterol | budesonide/glycopyrrolate/formoterol |
| Drug class | Inhaled Corticosteroid + LAMA + LABA | Inhaled Corticosteroid + LAMA + LABA |
| Treats | COPD, asthma | COPD |
| Category | Respiratory | Respiratory |
| Manufacturer | GSK | AstraZeneca |
| Year approved | 2017 | 2020 |
| FDA warning | No boxed warning | No boxed warning |
| Est. TV ad spend | $200M | $120M |
| Common side effects | Thrush, Respiratory infections, Headache, Cough | Respiratory infections, Thrush, Cough, Headache |
Trelegy Ellipta
Breztri Aerosphere
Frequently asked questions
Is Trelegy Ellipta or Breztri Aerosphere better?
Neither is universally "better." Trelegy Ellipta (fluticasone/umeclidinium/vilanterol) and Breztri Aerosphere (budesonide/glycopyrrolate/formoterol) are both used for respiratory, but the right choice depends on your medical history, insurance and your doctor's guidance. This comparison is informational only.
What's the difference between Trelegy Ellipta and Breztri Aerosphere?
Trelegy Ellipta is a Inhaled Corticosteroid + LAMA + LABA made by GSK, while Breztri Aerosphere is a Inhaled Corticosteroid + LAMA + LABA made by AstraZeneca. See the table above for a side-by-side breakdown.
Which one spends more on TV ads?
Trelegy Ellipta has the larger estimated TV advertising budget of the two.